Gram-Negative Bloodstream Infections in a Medical Intensive Care Unit: Epidemiology, Antibiotic Susceptibilities, and Risk Factors for in-Hospital Death
Guo Long,Peng Peng,Yuanming Li
DOI: https://doi.org/10.2147/idr.s493267
2024-11-27
Infection and Drug Resistance
Abstract:Guo Long, 1, 2 Peng Peng, 3 Yuanming Li 4 1 Department of Respiratory and Critical Care Medicine, The Third Xiangya Hospital of Central South University, Changsha, People's Republic of China; 2 Nursing Department, The Third Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China; 3 Clinical Laboratory Medicine Center, The Xiangya Hospital Zhuzhou of Central South University, Zhuzhou, People's Republic of China; 4 Department of Nephrology, The Third Xiangya Hospital of Central South University, Changsha, People's Republic of China Correspondence: Yuanming Li, Department of Nephrology, The Third Xiangya Hospital of Central South University, Changsha, 410013, People's Republic of China, Tel/fax +86 731 8861 8301, Email Purpose: Gram-negative bloodstream infection (GNBI) poses a serious threat to critically ill patients. This retrospective study aimed to uncover drug resistance of pathogens and the GNBI effect on in-hospital death and distinguish death risk factors in a medical intensive care unit (ICU). Patients and Methods: A retrospective study of all GNBI patients in the medical ICU of the Third Xiangya Hospital over 9 nine years was conducted. Blood samples were performed by a BACTEC 9240 system, MALDI-TOF MS, Bruker and Vitek-2 system. Logistic regression was used for analyzing risk factors for death. Results: Seventy-five episodes of GNBI developed in 68 (1.4%) out of 4954 patients over a span of 9 years. The most frequently isolated bacterium was Klebsiella pneumoniae , with the lungs as the predominant source of GNBI. The resistance rate of Gram-negative bacteria to polymyxin B was 11.6% after excluding those intrinsically resistant non-fermentative bacteria. All Enterobacter spp. were susceptible to ceftazidime/avibactam. Thirty-three (48.5%) patients underwent inappropriate empirical antibiotic treatment and 48 (70.6%) patients died during the hospitalization. Multivariate logistic regression analysis identified that lymphocyte count at GNBI onset ≤ 0.5× 10 9 /L, invasive mechanical ventilation, and septic shock were related to in-hospital death. Body mass index ≥ 23 and appropriate empirical antibiotic use after GNBI were negatively associated with in-hospital death. Conclusion: GNBI was a frequent complication among patients in the medical ICU. This study underscored the presence of diverse factors that either heightened or attenuated the risk of in-hospital death. Keywords: gram-negative bloodstream infections, antimicrobial susceptibility, risk factors, death, medical intensive care unit Despite progress in antibiotic treatment and other supportive care, bloodstream infections remain a significant threat to hospitalized patients, with an annual incidence of 204 cases per 100,000 individuals and a mortality rate ranging from 15% to 60%. 1,2 A multi-center study in 162 intensive care units (ICUs) from 24 countries suggested that most episodes of bloodstream infections were caused by multi-drug-resistant (MDR) Gram-negative bacteria. 3 An evaluation of Gram-negative bloodstream infections (GNBI) in Qatar highlighted that MDR GNBI was responsible for 13% of all GNBI episodes. 4 Patients with bloodstream infections due to Gram-negative bacteria, particularly MDR strains, face limited treatment choices and a significant risk of death, complications, and longer hospital stays. 5 A study involved 831 cases of healthcare-associated GNBI from 17 ICUs in Turkey uncovered that the all-cause mortality rate in GNBI patients exceeds 40%. 6 The mortality determinants of patients with GNBI have been studied previously in different patients. 7–16 Kalam et al conducted a prospective cohort study in Pakistan and found MDR GNBI, multiple positive cultures and a longer stay in ICU (>48 hours) were identified as significant risk factors for 2 week-mortality. 9 The predictors for 28 day- or 30 day- mortality included previous hospitalization 11 and ICU stay, 13 liver cirrhosis, 11 pulmonary infection, 13 coronary artery disease, 7 the incomplete remission status of underlying diseases, 14 elevated body mass index (BMI), 10 higher lymphocyte, 13 lower platelet count, 13 hypoproteinemia, 14 immune suppression 7 and central venous catheter use. 15 Charlson comorbidity index, 15 high acute physiology and chronic health evaluation II score, 11 and higher sequential organ failure assessment score at GNBI onset 8,15 also contributed to mortality. MDR bacteremia, including carbapenem-res -Abstract Truncated-
pharmacology & pharmacy,infectious diseases